NDC 81033-035-08 - TOPIRAMATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 81033-035
- Requested NDC
- 81033-035-08
- Package NDCs from labels
- 81033-035-04, 81033-035-14, 81033-035-06, 81033-035-15, 81033-035-08, 81033-035-16
- Manufacturer
- Kesin Pharma
- Effective date
- 2026-06-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| TOPIRAMATE - Kesin Pharma | Kesin Pharma | 2026-06-16 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| topiramate | TOPIRAMATE | A-S Medication Solutions | 8706a35d-5c39-4daf-b83a-65f3d630e043 | 2024-08-21 | Warnings, Adverse reactions | 0H73WJJ391 |
| Topiramate | TOPIRAMATE | Bryant Ranch Prepack | 61390be3-7553-4cb5-b5da-7571ed7d4b17 | 2024-08-20 | Warnings, Adverse reactions | 0H73WJJ391 |
| Topiramate | TOPIRAMATE | Bryant Ranch Prepack | ffaacad8-4594-45a8-b292-02a84cd0c35b | 2024-08-20 | Warnings, Adverse reactions | 0H73WJJ391 |
| Topiramate | TOPIRAMATE | Advanced Rx Pharmacy of Tennessee, LLC | b353e7fb-b976-96d8-e053-2995a90a110a | 2024-08-14 | Warnings, Adverse reactions | 0H73WJJ391 |
| topiramate | TOPIRAMATE | Zydus Lifesciences Limited | 57016639-89fe-43ad-89c4-5e7a756dddec | 2024-08-14 | 0H73WJJ391 | |
| Up and Up Hemorrhoid MAX STRENGTH | 14.4% GLYCERIN, 0.25% PHENYLEPHRINE HCL, 1% PRAMOXINE HCL, 15% PETROLATUM | Target Corporation | 867677b5-fd1d-449e-966e-1de0b5c98afb | 2024-08-08 | Warnings | PDC6A3C0OX |
| topiramate | TOPIRAMATE | Bryant Ranch Prepack | 654f7c48-8c5d-4b97-88d6-397696f82b6a | 2024-08-08 | Warnings, Adverse reactions | 0H73WJJ391 |
| topiramate | TOPIRAMATE | NuCare Pharmaceuticals,Inc. | 1ef1c408-30f7-51ee-e063-6394a90ac880 | 2024-08-05 | Warnings, Adverse reactions | 0H73WJJ391 |
| Topiramate | TOPIRAMATE | Bryant Ranch Prepack | e9cb3c29-098c-405f-a200-b436ac7fa1a2 | 2024-07-24 | Warnings, Adverse reactions | 0H73WJJ391 |
| Topiramate | TOPIRAMATE | NuCare Pharmaceuticals, Inc. | 4a656a9f-8eb8-69b7-e054-00144ff8d46c | 2024-07-19 | Warnings, Adverse reactions | 0H73WJJ391 |
| Zenibell Snail IntensiveCream | GLYCERIN | MISOCOS | 97c19dca-237c-c968-e053-2a95a90aeae7 | 2024-07-05 | Warnings | PDC6A3C0OX |
| Zenibell Snail Intensive Toner | GLYCERIN | MISOCOS | 97c1b556-824d-bef7-e053-2a95a90ae1f2 | 2024-07-05 | Warnings | PDC6A3C0OX |
| aewajin Derma Hydrocell | GLYCERIN | MISOCOS | 980fcaea-27ba-da49-e053-2995a90ad506 | 2024-07-05 | Warnings | PDC6A3C0OX |
| aewajin Derma Hydrocell 24k Gold Serum | GLYCERIN | MISOCOS | a17b2c6e-9db8-bae4-e053-2a95a90adcf6 | 2024-07-05 | Warnings | PDC6A3C0OX |
| Bunnies Bum Soothing Hemorrhoidal | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | FloCal Distributors LLC | 1c81582c-7ece-182f-e063-6294a90a8fbc | 2024-07-05 | Warnings | PDC6A3C0OX |
| Zenibell Snail Intensive | GLYCERIN | MISOCOS | 97747267-26f1-d06f-e053-2a95a90ab087 | 2024-07-04 | Warnings | PDC6A3C0OX |
| ABREVA Rapid Pain Relief | GLYCERIN, LIDOCAINE | Haleon US Holdings LLC | 65bd242f-4c6a-436c-8ec0-7b2e0d73ed9d | 2024-06-20 | Warnings | PDC6A3C0OX |
| Topiramate | TOPIRAMATE | NuCare Pharmaceuticals,Inc. | 9ddb8451-a455-87ec-e053-2995a90a5e5e | 2024-06-20 | Warnings, Adverse reactions | 0H73WJJ391 |
| topiramate | TOPIRAMATE | NuCare Pharmaceuticals,Inc. | 816566bf-b909-606f-e053-2a91aa0ab8c9 | 2024-06-14 | Warnings, Adverse reactions | 0H73WJJ391 |
| topiramate | TOPIRAMATE | NuCare Pharmaceuticals,Inc. | 87dc077b-2c84-522b-e053-2995a90a68bc | 2024-06-14 | Warnings, Adverse reactions | 0H73WJJ391 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.